Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Proctor

Showing results (191-200 of 197) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 197 results.
British Journal of Haematology|February 13, 2001
Haematologists' approaches to the management of adolescents and young adults with acute leukaemiaS Benjamin, M E Kroll, R A Cartwright, et al.
Journal of the American Chemical Society|July 4, 2025
Organic Carbon Monoxide Prodrugs Activated by Endogenous Reactive Oxygen Species for Targeted DeliveryInga Cernauskiene, Claudio D Navo, Carlos Labão-Almeida, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 5, 2026
A Bifunctional Small Molecule Degrader of the Long Noncoding RNA MALAT1 TriplexChristian A T Brega, Benjamin A Craig, Sigitas Mikutis, et al.
European Journal of Haematology. Supplementum|August 7, 2001
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacyS J Proctor, P R Taylor, B Angus, et al.
Histopathology|February 15, 2000
Monoclonal antibodies recognizing CD5, CD10 and CD23 in formalin-fixed, paraffin-embedded tissue: production and assessment of their value in the diagnosis of small B-cell lymphomaP Watson, K M Wood, A Lodge, et al.
Leukemia & Lymphoma|October 24, 2000
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacyG H Jackson, B Angus, P J Carey, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma GroupD A Cameron, J M White, S J Proctor, et al.
Pageof 20

Showing results (191-200 of 197) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
British Journal of Haematology|February 13, 2001
Haematologists' approaches to the management of adolescents and young adults with acute leukaemiaS Benjamin, M E Kroll, R A Cartwright, et al.
Journal of the American Chemical Society|July 4, 2025
Organic Carbon Monoxide Prodrugs Activated by Endogenous Reactive Oxygen Species for Targeted DeliveryInga Cernauskiene, Claudio D Navo, Carlos Labão-Almeida, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 5, 2026
A Bifunctional Small Molecule Degrader of the Long Noncoding RNA MALAT1 TriplexChristian A T Brega, Benjamin A Craig, Sigitas Mikutis, et al.
European Journal of Haematology. Supplementum|August 7, 2001
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacyS J Proctor, P R Taylor, B Angus, et al.
Histopathology|February 15, 2000
Monoclonal antibodies recognizing CD5, CD10 and CD23 in formalin-fixed, paraffin-embedded tissue: production and assessment of their value in the diagnosis of small B-cell lymphomaP Watson, K M Wood, A Lodge, et al.
Leukemia & Lymphoma|October 24, 2000
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacyG H Jackson, B Angus, P J Carey, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma GroupD A Cameron, J M White, S J Proctor, et al.
Pageof 20